Sanifit, owned by Ysios Capital, announces that the Phase 2b CaLIPSO trial of SNF472 met its primary endpoint
30/10/2019 Nota de prensa SANIFIT, OWNED BY YSIOS CAPITAL, ANNOUNCES THAT THE PHASE 2B CALIPSO TRIAL OF SNF472 MET ITS PRIMARY ENDPOINT. • Venture capital firm Ysios Capital led the 36,6M€ Series C round in 2015 creating a relevant international investors syndicate and continued supporting the company in the 55,2M€ Series D in 2019, the…